Aug 6, 2026 04:01PM
Jul 28, 2026 04:01PM
Jul 28, 2026 04:01PM
Jul 22, 2026 04:01PM
Jul 22, 2026 04:01PM
Jun 23, 2026 04:01PM
Jun 23, 2026 04:01PM VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors
Jun 17, 2026 07:31AM
Jun 17, 2026 07:30AM
Jun 16, 2026 04:01PM
Jun 16, 2026 04:01PM
Jun 15, 2026 04:01PM
Jun 9, 2026 02:00PM
Jun 3, 2026 04:01PM FDA grants fast track status to Verastem's lung cancer drug VS-7375
Jun 3, 2026 04:01PM
May 8, 2026 07:30AM
May 7, 2026 04:01PM
Apr 30, 2026 07:30AM
Apr 10, 2026 07:00AM
Apr 10, 2026 07:00AM
Mar 17, 2026 06:03PM Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
Mar 17, 2026 04:44PM
Mar 4, 2026 04:01PM
Feb 4, 2026 07:31AM
Feb 4, 2026 07:30AM
Dec 29, 2025 04:01PM
Dec 29, 2025 04:01PM
Dec 15, 2025 04:01PM Verastem Oncology names new chairman, president of development
Dec 15, 2025 04:01PM
Nov 14, 2025 12:41AM
Nov 14, 2025 12:41AM
Nov 13, 2025 04:07PM
Nov 13, 2025 04:07PM
Nov 4, 2025 07:30AM
Oct 23, 2025 04:01PM Verastem Oncology reports early trial data for KRAS G12D cancer drug
Oct 23, 2025 04:01PM
Oct 19, 2025 04:15AM
Oct 19, 2025 04:15AM
Sep 11, 2025 08:18AM
Aug 13, 2025 04:29PM
Aug 13, 2025 04:29PM
Aug 7, 2025 04:05PM Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
Jul 24, 2025 07:30AM
Jul 24, 2025 07:30AM
Jul 11, 2025 04:12PM
Jul 11, 2025 04:12PM
Jul 8, 2025 08:50AM
Jun 30, 2025 04:02PM
Jun 30, 2025 04:02PM Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade S
Jun 24, 2025 04:02PM

329,625 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All